European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading

European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.55% to 1,424.23 on the S&P Europe Select ADR Index, which is poised to end the week about 0.31% higher.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and semiconductor company Sequans Communications (SQNS), which advanced 10% and 2.5% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Novo Nordisk (NVO), which increased 2% and 1.8% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Grifols (GRFS), which fell 2.5% and 1.6% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and telecommunications company Nokia (NOK), which were down 1.1% and 0.6% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Bicycle Therapeutics (BCYC), which climbed 9.9% and 3.5% respectively. They were followed by software firm Endava (DAVA) and biotech firm Autolus Therapeutics (AUTL), which rose 2.8% and 1.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and insurance company Prudential (PUK), which lost 8.4% and 1.3% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and pharmaceutical company GSK (GSK), which were off 0.9% each.